SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-072448
Filing Date
2021-05-26
Accepted
2021-05-26 16:31:23
Documents
2
Group Members
AESCAP VENTURE MANAGEMENT B.V.JOHAN GERHARD BOSMANMICHIEL ALEXANDER DE HAANPATRICK JOHAN HENDRIK KROL

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a21-17386_1sc13da.htm SC 13D/A 126615
2 EX-99.1 a21-17386_1ex99d1.htm EX-99.1 22043
  Complete submission text file 0001104659-21-072448.txt   150475
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89626 | Film No.: 21966756
SIC: 2834 Pharmaceutical Preparations

Mailing Address BARBARA STROZZILAAN 101 AMSTERDAM P7 1083 HN
Business Address BARBARA STROZZILAAN 101 AMSTERDAM P7 1083 HN 31 20 570 29 45
Cooperatieve AESCAP Venture I U.A. (Filed by) CIK: 0001834629 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A